Skip to main content

Table 3 AE count and disability for each fluoroquinolone (counts)a

From: Evaluation of disability in patients exposed to fluoroquinolones

  1 confirmed qualifying AE1 confirmed qualifying AE
+ Disability
2+ confirmed qualifying AEs2 + confirmed qualifying AEs
+ Disability
Count Used for Any ConditionCount (Row %)
Levofloxacin49,9237559 (15.1%)472 (0.9%)1328 (2.7%)117 (0.2%)
Ciprofloxacin56,7927062 (12.4)530 (0.9)1109 (2.0)111 (0.2)
Moxifloxacin12,1171863 (15.4)105 (0.9)281 (2.3)34 (0.3)
Ofloxacin526 (11.5)0 (0.0)1 (1.9)0 (0.0)
Gemifloxacin785110 (14.0)5 (0.6)16 (2.0)2 (0.3)
Gatifloxacin200 (0.0)0 (0.0)0 (0.0)
Norfloxacin500 (0.0)0 (0.0)0 (0.0)
TOTAL119,67616,60011122735264
  1. Abbreviations: AE Adverse event
  2. aCounts above are not mutually exclusive